"Physiological vs Right Ventricular Pacing Outcome Trial Evaluated for bradyCardia Treatment" (PROTECT-HF)
Launched by IMPERIAL COLLEGE LONDON · Apr 4, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The PROTECT-HF trial is studying two different methods of pacing the heart to help people with slow heart rates, a condition known as bradycardia. This trial will compare the traditional method, called right ventricular pacing, with a newer approach known as physiological pacing, which includes techniques called His bundle pacing and left bundle branch area pacing. The study will involve around 2,600 patients who will be randomly assigned to receive one of the two pacing methods. Researchers will monitor patients’ progress over time to see which method works better for maintaining heart health.
To participate in this trial, individuals must be over 18 years old and have a heart function that is still above a certain level, with specific heart rhythm issues that require a pacemaker. For example, those with various types of heart block or slow atrial fibrillation may qualify. Participants can expect to have their pacemaker implanted at one of the study centers, and their health will be monitored regularly for two years. Importantly, both patients and the assessors will not know which pacing method a participant receives to ensure an unbiased study. This trial aims to improve our understanding of how these pacing techniques affect heart function over time.
Gender
ALL
Eligibility criteria
- • We will recruit patients who are referred for clinically indicated pacemaker implantation
- Inclusion Criteria:
- 1. Adults aged over 18 with left ventricular ejection fraction \>35% and one or more of the following guideline based ventricular pacing indications:
- • 1. Permanent or intermittent 3rd degree AV block
- • 2. Permanent or intermittent Mobitz type II AV block
- • 3. First Degree AV block with a pacing indication
- • 4. Slow chronic Atrial Fibrillation or Proposed AV node ablation
- • 5. Bifascicular block with a pacing indication
- • 6. Trifascicular block with a pacing indication
- • 7. Wenckebach with a pacing indication
- Exclusion Criteria:
- • 1. Patients who are likely to only need occasional ventricular pacing, i.e. those with isolated sick sinus syndrome.
- • 2. Pregnant women.
- • 3. Unable to provide informed consent.
- • 4. Those with comorbidity leading to a life expectancy \<1year.
About Imperial College London
Imperial College London is a world-renowned research institution based in the United Kingdom, recognized for its commitment to advancing medical science and improving patient care through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, Imperial combines expertise across various fields, including medicine, engineering, and business, to drive breakthroughs in healthcare. The institution’s robust clinical trial programs are designed to evaluate new therapies and interventions, ensuring rigorous scientific standards and ethical practices while aiming to translate research findings into tangible benefits for patients and society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Aberdeen, , United Kingdom
Edinburgh, , United Kingdom
Nottingham, , United Kingdom
Rotherham, , United Kingdom
Torquay, , United Kingdom
London, , United Kingdom
Leicester, , United Kingdom
Birmingham, , United Kingdom
London, , United Kingdom
Bristol, , United Kingdom
Taunton, , United Kingdom
Chichester, , United Kingdom
York, , United Kingdom
Plymouth, , United Kingdom
Oxford, , United Kingdom
Liverpool, , United Kingdom
Brighton, , United Kingdom
Portsmouth, , United Kingdom
Swansea, , United Kingdom
Middlesbrough, , United Kingdom
Reading, , United Kingdom
Dublin, , Ireland
Larbert, , United Kingdom
Coventry, , United Kingdom
Slough, , United Kingdom
Gillingham, , United Kingdom
Leeds, , United Kingdom
Nottingham, , United Kingdom
High Wycombe, , United Kingdom
Birmingham, , United Kingdom
Cambridge, , United Kingdom
Fife Keith, , United Kingdom
Bournemouth, , United Kingdom
Croydon, , United Kingdom
London, , United Kingdom
London, , United Kingdom
London, , United Kingdom
Redhill, , United Kingdom
Sheffield, , United Kingdom
Southampton, , United Kingdom
Swindon, , United Kingdom
Worthing, , United Kingdom
Ljubljana, , Slovenia
Barking, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials